BOSTON BIO SYSTEMS LTD. Stock Screener | Share Price & Fundamental Analysis
BOSTONBIO
Healthcare Service Provider
Screen BOSTON BIO SYSTEMS LTD. share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹8.20
▲
0.22 (2.76%)
Market Cap
₹5.04 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
0.81
EPS (TTM)
₹-0.78
Dividend Yield
-
Debt to Equity
0.51
52W High
₹20.90
52W Low
₹6.58
Operating Margin
-42.00%
Profit Margin
-100.00%
Revenue (TTM)
₹1.00
EBITDA
-
Net Income
₹-1.00
Total Assets
₹15.00
Total Equity
₹6.00
BOSTON BIO SYSTEMS LTD. Share Price History - Stock Screener Chart
Screen BOSTONBIO historical share price movements with interactive charts. Analyze price trends and patterns.
BOSTON BIO SYSTEMS LTD. Company Profile - Fundamental Screener
Screen BOSTON BIO SYSTEMS LTD. company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for BOSTONBIO shares.
Sector
Healthcare Services
Industry
Healthcare Service Provider
Sub-Sector
Healthcare Service Provider
Segment
E
ISIN
INE109B01019
BOSTON BIO SYSTEMS LTD. Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen BOSTONBIO balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Total Assets | 15 | 11 | 11 | 11 | 10 | 9 | 9 | 7 |
| Current Assets | 9 | 5 | 5 | 5 | 4 | 4 | 3 | 1 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Liabilities | ||||||||
| Total Liabilities | 15 | 11 | 11 | 11 | 10 | 9 | 9 | 7 |
| Current Liabilities | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||
| Total Equity | 6 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Share Capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Reserves & Surplus | -1 | -1 | 0 | 0 | 0 | 0 | 0 | 0 |
Screen BOSTONBIO income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 0 |
| Expenses | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 2 | 0 |
| EBITDA | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit % | -42.00% | -284.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -1 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS | -0.60 | -0.78 | -0.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
BOSTON BIO SYSTEMS LTD. Cash Flow Screener - Liquidity Fundamentals
Screen BOSTONBIO cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | -5 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 |
| Financing Activities | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Screen BOSTONBIO shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 2.14% | 2.14% | 2.14% | 2.14% | 2.14% | 2.14% | 2.14% | 2.14% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 85.21% | 85.33% | 84.78% | 85.14% | 85.14% | 85.14% | 85.14% | 85.14% |
| Other Holding | 12.64% | 12.53% | 13.08% | 12.72% | 12.72% | 12.72% | 12.72% | 12.72% |
| Shareholder Count | 1,385 | 1,295 | 1,147 | 1,141 | 1,141 | 1,141 | 1,141 | 1,141 |
BOSTON BIO SYSTEMS LTD. Dividend Screener - Share Yield Analysis
Screen BOSTONBIO dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
BOSTON BIO SYSTEMS LTD. Index Membership - Market Screener Classification
Screen BOSTONBIO by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
BOSTON BIO SYSTEMS LTD. Market Events Screener - Corporate Actions
Screen BOSTONBIO market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -1.09% | ||
| Annual General Meeting | NA | - | ||
| Annual General Meeting | NA | - | ||
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -4.80% |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | 1.91% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | -3.84% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | - |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | - |
BOSTON BIO SYSTEMS LTD. Competitors Screener - Peer Comparison
Screen BOSTONBIO competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 24,841 | 45.21 | 2,555 | 11.28% | 492 | 54.65 |
| Vijaya Diagnostic Centre | 10,899 | 70.73 | 700 | 23.06% | 144 | 64.28 |
| Metropolis Healthcare | 9,996 | 60.67 | 1,346 | 10.64% | 146 | 52.50 |
| Thyrocare Technologies | 7,094 | 56.80 | 702 | 20.80% | 91 | 47.93 |
| Nephrocare Health Services | 4,703 | 69.33 | 770 | 33.97% | 67 | |
| Krsnaa Diagnostics | 2,340 | 27.13 | 743 | 16.70% | 78 | 40.75 |
| Suraksha Diagnostic | 1,404 | 44.71 | 256 | 15.11% | 31 | 35.69 |
| One Global Service Provider | 1,244 | 28.19 | 148 | 134.60% | 19 | 60.12 |
| 3B BlackBio DX | 1,206 | 24.82 | 112 | 28.72% | 48 | 55.34 |
| Sastasundar Ventures | 939 | -104.79 | 1,171 | -18.47% | -134 | 38.51 |
BOSTON BIO SYSTEMS LTD. Company Announcements - News Screener
Screen BOSTONBIO latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-06 | Closure of Trading Window | View |
| 2025-11-27 | Announcement under Regulation 30 (LODR)-Change of Company Name | View |
| 2025-11-15 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-14 | Considered And Approved The Standalone Un-Audited Financial Results Of The Company For The Quarter And Half Ended On 30Th September 2025. | View |
| 2025-11-14 | Board Meeting Outcome for Outcome Of Board Meeting Pursuant To Regulation 30 Of SEBI (Listing Obligation & Disclosure Requirements) Regulation 2015 Held Today I.E. 14Th November 2025 | View |
| 2025-11-07 | Board Meeting Intimation for Prior Intimation Of Date Of Board Meeting For Considering The Unaudited Financial Results Of The Company For The Quarter And Half Year Ended September 30 2025. | View |
| 2025-10-14 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-13 | Board Meeting Outcome for Outcome Of Board Meeting Held On 13Th October 2025 Regarding Change In Management- Resignation And Appointment Of Company Secretary | View |
| 2025-10-11 | Reg. 34 (1) Annual Report. | View |
| 2025-10-03 | Reg. 34 (1) Annual Report. | View |
| 2025-10-01 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-10-01 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-30 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-26 | Closure of Trading Window | View |
| 2025-09-05 | Intimation For Book Closure | View |
| 2025-09-05 | Reg. 34 (1) Annual Report. | View |
| 2025-09-05 | Notice For 30Th Annual General Meeting To Be Held On 30Th September 2025 | View |
| 2025-09-04 | Board Meeting Outcome for Outcome Of Board Meeting Held On 4Th September 2025 | View |
| 2025-09-04 | Outcome Of The Board Meeting Held On 04Th September 2025 | View |
| 2025-08-18 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |